Additionally, it has been shown that the withdrawal of antiangiogenic therapy results in accelerated tumor growth and that FAK activation mediates this tumor rebound, which increases angiogenesis and platelet infiltration (Figure 4A) [200]. The gene discussed is PTK2; the disease is neoplasm.